In-silico evaluation of diffractaic acid as novel anti-diabetic inhibitor against dipeptidyl peptidase IV enzyme. - Roney M; Issahaku AR; Dubey A; Tufail A; Istiaque Hamim SM; Wilhelm A; Aluwi MFFM (In silico pharmacology, 2025)